HARBOR CAPITAL ADVISORS, INC.

Position in RARE — Ultragenyx Pharmaceutical Inc.

CIK 1039128 CHICAGO, IL

Position in RARE

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$2,414,631

+$671,675 QoQ

Shares Held

72,316

-13.1% QoQ

Ownership

0.073%

of shares outstanding

% of Portfolio

0.19%

of 13F equity value

Holder Rank

#115

of 310 holders

Holding Since

Mar 2022

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HARBOR CAPITAL ADVISORS, INC. holds $28,134,645 across 28 Biotechnology names. RARE ranks #4 (8.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KYMR	Kymera Therapeutics, Inc.	36,368	$4,170,318
2	VCEL	Vericel Corp	72,852	$3,241,185
3	HALO	Halozyme Therapeutics, Inc.	36,977	$2,894,189
4	RARE	Ultragenyx Pharmaceutical Inc. This page	72,316	$2,414,631
5	CELC	Celcuity Inc.	19,933	$2,085,390
6	TARS	Tarsus Pharmaceuticals, Inc.	29,612	$1,863,779
7	AGIO	Agios Pharmaceuticals, Inc.	46,550	$1,727,470
8	SRPT	Sarepta Therapeutics, Inc.	92,669	$1,665,261

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,414,631	72,316	-13.1%	Shares	Sole	2026-08-07
2026-03-31	$1,742,956	83,196	+138.2%	Shares	Sole	2026-04-28
2023-12-31	$1,670,352	34,930	+9.6%	Shares	Sole	2024-01-08
2023-09-30	$1,136,593	31,882	+22.8%	Shares	Sole	2023-10-20
2023-06-30	$1,198,088	25,972	+1047.2%	Shares	Sole	2023-07-11
2022-12-31	$104,891	2,264	+26.1%	Shares	Sole	2023-01-20
2022-09-30	$74,330	1,795	-38.5%	Shares	Sole	2022-10-28
2022-06-30	$174,087	2,918	+25.5%	Shares	Sole	2022-07-26
2022-03-31	$168,914	2,326	—	Shares	Sole	2022-04-28
No filing history on record for this holder in this stock.